Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 August, 2018 01:56 IST
Dr. Reddy's Lab gets EIR from USFDA for Hyderabad facility
Source: IRIS | 12 Dec, 2017, 09.50AM
Comments  |  Post Comment

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the US Food & Drug Administration (USFDA) for its Formulations Manufacturing Plant-3 at Bachupally, Hyderabad as closure of audit.

Earlier in April, USFDA had inspected the Formulations Manufacturing Plant-3 wherein it had issued a form 483 with 11 observations.

The stock had underperformed the market over the past one month till Dec. 11, 2017, falling 6.84% compared with the Sensex's 0.42% rise. It underperformed the market in past one quarter, gaining 1.22% as against 4.94% rise in the Sensex.

Shares of the company gained Rs 88.45, or 4.03%, to trade at Rs 2,281.95. The total volume of shares traded was 41,519 at the BSE (9.39 a.m., Tuesday).



Dr Reddy`S Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Ion Exchange secures EPC contract worth Rs 4.38 bn - 17-Aug-2018 11:35
IL&FS Transportation Networks to receive Rs 430 mn from Ramky Infra - 17-Aug-2018 11:32
IL&FS Transportation Networks to receive Rs 430 mn from Ramky Infra - 17-Aug-2018 11:32
Ashok Leyland wins overseas order for 300 double decker buses - 17-Aug-2018 09:51
NBCC secures work order worth Rs 2.50 bn from SAIL - 16-Aug-2018 15:35
NBCC secures work order worth Rs 2.50 bn from SAIL - 16-Aug-2018 15:35
MCX inks MoU with Indian Bullion and Jewellers Association - 16-Aug-2018 15:31
Alfa Transformers bags order worth Rs 171.1 mn from Uttar Gujarat Vij Co - 16-Aug-2018 12:25
TVS Motor Co bets big on Philippines with new product launches - 16-Aug-2018 09:54
Sun Pharma gets USFDA approval for Cequa ophthalmic solution - 16-Aug-2018 09:33
TCS named leader in KYC-AML BPO services by Everest Group - 14-Aug-2018 12:04
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer